{"url":"https://newsforagent.com/news/2026-11-08/raise-medical-research-fund-first-close","markdown_url":"https://newsforagent.com/news/2026-11-08/raise-medical-research-fund-first-close.md","title":"RAISE Raises €100 Million for Medical Research Fund","headline":"RAISE Secures €100 Million First Close for Medical Research Fund Targeting €200 Million","description":"RAISE raised €100 million at the first close of its Investir pour la Recherche Médicale fund, co-led by AXA.","section":"Funding","published_at":"2026-11-08T01:32:45+00:00","modified_at":"2026-11-08T01:32:45+00:00","author":"News Desk","key_takeaways":["RAISE raised €100 million at the first close of Investir pour la Recherche Médicale, which targets €200 million.","AXA, Banque des Territoires and Crédit Agricole Assurances co-led the fundraising, with other institutional and corporate investors participating.","The fund will donate 50% of its first-year management fees and 50% of net gains to four medical research institutions."],"companies":[{"name":"RAISE","is_primary":true,"profile_url":"https://akta.pro/company-profiles/00021wm/raise","website":"http://www.raise.co"},{"name":"Credit Agricole Assurances","is_primary":false,"profile_url":"https://akta.pro/company-profiles/0004j96/credit-agricole-assurances","website":"https://www.ca-assurances.com"},{"name":"AXA Group","is_primary":false,"profile_url":"https://akta.pro/company-profiles/0000jkw/axa-group","website":"https://www.axa.com"}],"source":{"publisher":"The future of trading","title":"Raise secures EUR 100 million at first close of medical research fund","url":"https://capital.com/en-int/news/raise-secures-eur-100-million-at-first-close-of-medical"},"other_sources":[],"tags":["Funding","RAISE","Credit Agricole Assurances","AXA Group"],"body_markdown":"RAISE raised €100 million at the first close of Investir pour la Recherche Médicale, a fund targeting €200 million, with AXA, Banque des Territoires and Crédit Agricole Assurances co-leading the fundraising. [The future of trading](https://capital.com/en-int/news/raise-secures-eur-100-million-at-first-close-of-medical) reported the first close on November 8, 2026.\n\n## RAISE's Medical Research Fund and Its Co-Leads\n\n[RAISE](https://akta.pro/company-profiles/00021wm/raise) said other institutional and corporate investors also participated in the first close alongside the three co-leads. The fund's strategy targets minority co-investments in buyouts and growth capital across France and Europe.\n\nThe fund will donate 50% of management fees from its first year, and four medical research institutions will receive 50% of net gains. [AXA](https://akta.pro/company-profiles/0000jkw/axa-group) and Crédit Agricole Assurances are among the named co-leads. Crédit Agricole Assurances appointed Philippe Toulorge as chief digital and customer marketing officer, MarketScreener reported on September 23, 2026; he has been on the executive committee since January 2022 and previously served as chief information officer within the group's insurance subsidiary.\n\n## RAISE's Earlier Capital Increases\n\nAccording to akta.pro [company records](https://akta.pro/company-data), RAISE Invest completed a €120 million capital increase in April 2024, bringing its own funds to €650 million. In March 2026, French savings institution Carac Group acquired a 30% minority stake in RAISE Group, while co-founders and management retained a 70% majority.\n\nThe same records list RAISE's assets under management at €2 billion across five investment strategies and more than 80 portfolio company equity investments since 2013. RAISE was founded in 2013 and is headquartered in Paris.\n\n| Date | Event | Figure |\n| --- | --- | --- |\n| April 2024 | RAISE Invest capital increase | €120 million |\n| April 2024 | RAISE Invest own funds after increase | €650 million |\n| March 2026 | Carac Group minority stake in RAISE Group | 30% |\n| March 2026 | Co-founders and management retained majority | 70% |\n| November 2026 | Investir pour la Recherche Médicale first close | €100 million |\n| November 2026 | Investir pour la Recherche Médicale target | €200 million |\n\n## Fund Target and Research Donations\n\nThe fund is targeting €200 million in total, against the €100 million raised at the first close. Four medical research institutions will receive 50% of net gains, and the fund will donate 50% of management fees from its first year.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}